Skip to main content

Diabetes complications and comorbidities: Hyperglycemia

medwireNews

04-10-2023 | Hyperglycemia | News

High incidence of alpelisib‐associated hyperglycemia in routine care

A retrospective analysis has found a significantly higher incidence of hyperglycemia among breast cancer patients treated with alpelisib in standard care than on clinical trials.

20-09-2022 | EASD 2022 | Conference coverage | News

Freestyle Libre cuts acute complication risk in insulin-treated type 2 diabetes

People taking basal insulin to treat type 2 diabetes experience a significant reduction in the risk for acute complications, which is sustained for at least 2 years after initiating use of the Freestyle Libre, say French researchers.

13-06-2022 | Artificial pancreas systems | News

Researchers calculate unannounced snack threshold for closed-loop system

Children and adolescents using an advanced hybrid closed-loop system for type 1 diabetes can tolerate an unannounced snack containing 20 g of carbohydrate without excessive blood sugar fluctuations, Italian researchers report.

08-06-2022 | ADA 2022 | Conference coverage | News

Overnight glycemic variability may impact next day function

Fluctuations in blood glucose levels during the night can adversely impact the psychologic and physical function of people with type 1 diabetes during the following day, report researchers.

X-ray of fractured forearm shaft of radius and ulnar bone on red mark

24-05-2022 | Bone health | News

Poor glycemic control, kidney disease linked to bone fragility in type 1 diabetes

Higher glycated hemoglobin and the presence of kidney disease are associated with lower bone mineral density in people with type 1 diabetes, study results show.

19-04-2022 | Older adults | News

Sustained benefits of CGM in older people with type 1 diabetes

Follow-up results from the WISDM trial show that extended use of continuous glucose monitoring leads to reduced hypoglycemia without increasing hyperglycemia risk in older people with type 1 diabetes.

11-03-2022 | Insulin pumps | News

Insulin pump infusion set failures most common in youngest users

Insulin pump infusion set failures that result in prolonged hyperglycemia occur an average of four times per year per user and are more common in children and adolescents than adults, US study findings indicate.

19-01-2022 | Artificial pancreas systems | News

Closed-loop benefits differ with high or low baseline HbA1c

Researchers find that the type of benefits people with type 1 diabetes gain from hybrid closed-loop insulin delivery differs according to their baseline glycemic control.

Person checking glucose level

15-04-2021 | Hyperglycemia | News

Hyperglycemia aversiveness linked to increased hypoglycemia exposure

People with type 1 diabetes who are “hyperglycemia aversive” reduce their hyperglycemia exposure at the cost of increased hypoglycemia and, potentially, reduced hypoglycemia awareness, research suggests.

13-11-2020 | Disordered eating | News

Very high blood glucose may hint at disordered eating in type 1 diabetes

Women with type 1 diabetes and a history of disordered eating spend markedly more time in level 2 hyperglycemia than women without eating disorders, show the results of a small continuous glucose monitoring study.

30-10-2020 | COVID-19 | News

Diabetes does not impair COVID-19 antibody response

The humoral immune response to SARS-CoV-2 infection is similar in people with and without diabetes and is not influenced by hyperglycemia, research suggests.

20-07-2020 | Flash glucose monitoring | News

More evidence for acute complication reduction with real-world flash glucose monitoring

UK audit data confirm multiple benefits linked to real-world use of flash glucose monitoring including reduced paramedic callouts and hospital admissions for acute diabetes complications.

03-07-2020 | Physical activity | News

Fructose boost may alleviate type 1 diabetes exercise-induced hypoglycemia risk

Consuming a single shot of fructose prior to exercise is a feasible strategy to reduce the risk for exercise-induced hypoglycemia among men with type 1 diabetes treated with insulin degludec, suggest findings from a proof-of-concept study.

23-06-2020 | ADA 2020 | Conference coverage | News

​​​​​​​CGM predictive low glucose alerts may prevent rebound hyperglycemia

Predictive low glucose alerts are associated with a reduced frequency and severity of rebound hyperglycemia among people using real-time continuous glucose monitoring, show study findings presented at the virtual ADA 80th Scientific Sessions.

Abbott Freestyle Libre

14-06-2020 | ADA 2020 | Conference coverage | News

​​​​​​​FreeStyle Libre use linked to substantial reduction in acute diabetes complications

Real-world data presented at the virtual ADA 80th Scientific Sessions highlight the benefits of the FreeStyle Libre continuous glucose monitoring system in reducing acute complications in people with type 1 or type 2 diabetes.

09-06-2020 | COVID-19 | News

Diabetes may present greatest risk to COVID-19 patients when newly diagnosed

Diabetes may present a higher risk to patients with COVID-19 if it is newly diagnosed at hospital admission rather than well established, indicates research from China.

Gym class jumping on boxes

22-05-2020 | Physical activity | Highlight | News

Hybrid insulin regimen may address type 1 diabetes exercise issues

A proof-of-concept study indicates that taking some basal insulin as a single injection of degludec improves glucose control during and after exercise in people with type 1 diabetes who prefer to remove their insulin pump while exercising.

27-04-2020 | COVID-19 | News

Uncontrolled hyperglycemia might be COVID-19 mortality risk factor

A descriptive analysis of US patients with COVID-19 reports a high in-hospital mortality rate in those with uncontrolled hyperglycemia.

13-11-2019 | Ketoacidosis | News

Hyperglycemic crisis combination linked with hospital deaths

A study of more than a thousand patients suggests that having both diabetic ketoacidosis and a hyperosmolar hyperglycemic state on arrival at hospital leads to more than twice the likelihood of death there than either condition alone.

25-09-2019 | Hypoglycemia | EASD 2019 | News

Daytime hyperglycemia, nocturnal hypoglycemia remain problems for EDIC cohort

People with type 1 diabetes rarely achieve the current targets for blood glucose control, with nocturnal hypoglycemia remaining a particular concern, shows an analysis of the DCCT/EDIC cohort.